SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-063895
Filing Date
2024-05-21
Accepted
2024-05-21 17:01:25
Documents
1
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2414996-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2414996-5_4seq1.xml 4 6442
  Complete submission text file 0001104659-24-063895.txt   8013
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O JAGUAR ANIMAL HEALTH, INC. 185 BERRY ST., SUITE 1300 SAN FRANCISCO CA 94107
Business Address
King Steven R. (Reporting) CIK: 0001622052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36714 | Film No.: 24970399